BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24705721)

  • 1. Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.
    Nikolaidis NM; White MR; Allen K; Tripathi S; Qi L; McDonald B; Taubenberger J; Seaton BA; McCormack FX; Crouch EC; Hartshorn KL
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1036-44. PubMed ID: 24705721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation.
    Goh BC; Rynkiewicz MJ; Cafarella TR; White MR; Hartshorn KL; Allen K; Crouch EC; Calin O; Seeberger PH; Schulten K; Seaton BA
    Biochemistry; 2013 Nov; 52(47):8527-38. PubMed ID: 24224757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo.
    Crouch E; Nikolaidis N; McCormack FX; McDonald B; Allen K; Rynkiewicz MJ; Cafarella TM; White M; Lewnard K; Leymarie N; Zaia J; Seaton BA; Hartshorn KL
    J Biol Chem; 2011 Nov; 286(47):40681-92. PubMed ID: 21965658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
    Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity.
    Hartshorn KL; White MR; Smith K; Sorensen G; Kuroki Y; Holmskov U; Head J; Crouch EC
    Scand J Immunol; 2010 Jul; 72(1):22-30. PubMed ID: 20591072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral aggregating and opsonizing activity in collectin trimers.
    Hartshorn KL; White MR; Tecle T; Sorensen G; Holmskov U; Crouch EC
    Am J Physiol Lung Cell Mol Physiol; 2010 Jan; 298(1):L79-88. PubMed ID: 19837850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Antiviral Activity of Human Surfactant Protein D by Site-Specific Engineering of the Carbohydrate Recognition Domain.
    van Eijk M; Hillaire MLB; Rimmelzwaan GF; Rynkiewicz MJ; White MR; Hartshorn KL; Hessing M; Koolmees PA; Tersteeg MH; van Es MH; Meijerhof T; Huckriede A; Haagsman HP
    Front Immunol; 2019; 10():2476. PubMed ID: 31749796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D.
    Hartshorn KL; White MR; Tecle T; Holmskov U; Crouch EC
    J Immunol; 2006 Jun; 176(11):6962-72. PubMed ID: 16709857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus.
    van Eijk M; Rynkiewicz MJ; Khatri K; Leymarie N; Zaia J; White MR; Hartshorn KL; Cafarella TR; van Die I; Hessing M; Seaton BA; Haagsman HP
    J Biol Chem; 2018 Jul; 293(27):10646-10662. PubMed ID: 29769321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.
    Tecle T; White MR; Sorensen G; Gantz D; Kacak N; Holmskov U; Smith K; Crouch EC; Hartshorn KL
    Biochem J; 2008 Jun; 412(2):323-9. PubMed ID: 18302538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Evasion of Innate Immune Defense: The Case of Resistance of Pandemic H1N1 Influenza A Virus to Human Mannose-Binding Proteins.
    White MR; Nikolaidis NM; McCormack F; Crouch EC; Hartshorn KL
    Front Microbiol; 2021; 12():774711. PubMed ID: 34956139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.
    Job ER; Deng YM; Barfod KK; Tate MD; Caldwell N; Reddiex S; Maurer-Stroh S; Brooks AG; Reading PC
    J Immunol; 2013 Mar; 190(5):2169-77. PubMed ID: 23365085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
    Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
    J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.
    Crouch E; Hartshorn K; Horlacher T; McDonald B; Smith K; Cafarella T; Seaton B; Seeberger PH; Head J
    Biochemistry; 2009 Apr; 48(15):3335-45. PubMed ID: 19249874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.
    Verma A; White M; Vathipadiekal V; Tripathi S; Mbianda J; Ieong M; Qi L; Taubenberger JK; Takahashi K; Jensenius JC; Thiel S; Hartshorn KL
    J Immunol; 2012 Sep; 189(5):2478-87. PubMed ID: 22851708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.
    Hartshorn KL; Webby R; White MR; Tecle T; Pan C; Boucher S; Moreland RJ; Crouch EC; Scheule RK
    Respir Res; 2008 Sep; 9(1):65. PubMed ID: 18811961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies.
    Job ER; Deng YM; Tate MD; Bottazzi B; Crouch EC; Dean MM; Mantovani A; Brooks AG; Reading PC
    J Immunol; 2010 Oct; 185(7):4284-91. PubMed ID: 20817882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
    Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
    PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.